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of standard radiotherapy field borders in patients
with uterine cervix cancer*
Ressonância magnética para avaliação dos limites dos campos clássicos de radioterapia
em pacientes portadoras de neoplasia maligna de colo uterino
Geison Moreira Freire1, Rodrigo Souza Dias2, Adelmo José Giordani3, Julisa Chamorro
Lascasas Ribalta4, Helena Regina Comodo Segreto5, Roberto Araujo Segreto6
OBJECTIVE: To evaluate, by means of magnetic resonance imaging, the standardized field borders in
radiotherapy for malignant neoplasm of uterine cervix, and to determine the role of this method in the reduction
of possible planning errors related to the conventional technique. MATERIALS AND METHODS: Magnetic
resonance imaging studies for planning of treatment of 51 patients with uterine cervix cancer were
retrospectively analyzed. The parameters assessed were the anterior and posterior field borders on sagittal
section. RESULTS: The anterior field border was inappropriate in 20 (39.2%) patients and geographic miss
was observed in 37.3% of cases in the posterior border. The inappropriateness of both field borders did not
correlate with clinical parameters such as patients’ age, tumor staging, histological type and degree.
CONCLUSION: The evaluation of standardized field borders with the use of magnetic resonance imaging has
demonstrated high indices of inappropriateness of the lateral field borders, as well as the relevant role of
magnetic resonance imaging in the radiotherapy planning for patients with uterine cervix cancer with a view
to reduce the occurrence of geographic miss of the target volume.
Keywords: Uterine cervix cancer; Radiotherapy planning; Magnetic resonance imaging; Geographic miss;
Tumor volume.
OBJETIVO: Avaliar os limites de campo padronizados para radioterapia de neoplasia maligna de colo uterino
com o uso de ressonância magnética e verificar a importância deste exame na redução de possíveis erros de
planejamento com técnica convencional. MATERIAIS E MÉTODOS: Foram analisados, retrospectivamente,
exames de ressonância magnética do planejamento de 51 pacientes tratadas devido a neoplasia de colo uterino.
Os parâmetros estudados foram limites anterior e posterior no corte sagital. RESULTADOS: Observou-se, no
corte sagital das ressonâncias magnéticas, que o limite de campo anterior apresentou-se inadequado em 20
(39,2%) pacientes e que houve perda geográfica em 37,3% dos casos no limite posterior. A inadequação de
ambos os limites de campo não se relacionou com parâmetros clínicos como idade das pacientes, estadia-
mento, tipo e grau histológico. CONCLUSÃO: A avaliação dos limites de campo padronizados pela literatura
com o uso de ressonância magnética mostrou altos índices de inadequação dos limites do campo lateral,
assim como a importância do uso deste exame no planejamento radioterápico de pacientes portadoras de
câncer de colo uterino com a finalidade de reduzir a perda geográfica no volume alvo de tratamento.
Unitermos: Câncer de colo uterino; Radioterapia; Imagem por ressonância magnética; Perda geográfica; Volume
tumoral.
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countries and, in some of them, this is the
type of cancer with highest incidence in the
female population(1). The Brazilian Cancer
Institute (Instituto Nacional de Câncer –
INCA) has estimated the occurrence of
18,430 new cases of this disease in 2010,
with an estimated risk of 18 cases in every
100,000 women(2).
Radiotherapy plays a significant role as
a therapeutic strategy for this disease, with
curative or even palliative purposes. Two
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INTRODUCTION
Uterine cervix cancer is the second most
frequent neoplasm among women. Most of
these patients are found in developing
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radiotherapy modalities are employed in
the management of this tumor, namely, tele-
therapy and brachytherapy. Teletherapy is
a technique where the radiation source is
distant from the target lesion, and is utilized
in the treatment of the whole pelvis, includ-
ing the lesion, uterus, vagina, parametrium
and the regional lymphatic system. In
brachytherapy, the radiation source is
placed in direct contact with the target vol-
ume to be treated(3–5).
In teletherapy, the most frequently uti-
lized technique includes four radiotherapy
fields, namely, one anterior field, another
posterior, and two latero-lateral fields, cov-
ering the whole target volume to be
treated(6).
Besides the staging methods recom-
mended by International Federation of Gy-
necology and Obstetrics (FIGO), magnetic
resonance imaging (MRI) is a valuable
method for women with this disease, since
it allows the delineation of the typical fe-
male pelvic anatomy and mainly the evalu-
ation of the local tumor extent(7,8).
The present study was aimed at evalu-
ating the standard radiotherapy field bor-
ders by means of MRI in cases of uterine
cervix cancer, , and to determine the role
of this method in the reduction of possible
planning errors related to the conventional
technique.
MATERIALS AND METHODS
Before undergoing radiotherapy, 51 pa-
tients were staged according to the FIGO
criteria and submitted to radiotherapy plan-
ning with orthogonal radiography and
simulation of treatment fields, defining
field borders based on bone references
standardized by the literature.
Inclusion criteria were the following:
patients aged ≥ 21 years, anatomopatho-
logically confirmed diagnosis of uterine
cervix neoplasm, patients with clinical
stages IB to IVA (FIGO) and patients sub-
mitted to pretreatment MRI. Exclusion cri-
teria were the following: contraindication
for MRI, patients previously submitted to
therapy and presence of another concomi-
tant or previously treated pelvic neoplasm.
In the classical radiotherapy planning,
the following parameters are utilized as
limits for the anterior and posterior fields:
the transition between the fourth and fifth
lumbar vertebrae, the lower border of the
obturator foramen or pubis, depending on
the vaginal involvement, and laterally, at
1.5 cm from the small pelvis margin. For
the lateral fields, the anterior border (AB)
is the pubic symphysis, and the posterior
border (PB) is the transition between the
second and third sacral vertebrae (S2-S3)
or including the whole vertebra S3(4). All
the patients underwent pelvic MRI before
initiating the treatment. Sagittal T1- and
T2-weighted sequences were performed in
a Philips 1.0 tesla equipment.
With the assistance of a radiologist, the
treatment volumes were delineated on MRI
studies, considering the tumor and the uter-
ine body as target volume, and the section
demonstrating the volume with the largest
anteroposterior diameter was selected. The
MRI studies were retrospectively analyzed
as regards the inclusion of the target vol-
ume in the standard radiotherapy fields.
The following parameters were evaluated:
anterior and posterior borders on the sag-
ittal section at the level of the median line.
A 1.0 cm safety margin around the tumor
and the uterine body was adopted.
The data obtained in the present study
were submitted to statistical analysis. Lo-
gistic regression was the inferential analy-
sis employed to either confirm or reject the
evidences observed in the descriptive
analysis. The significance level for null hy-
pothesis rejection was p ≤ 0.05.
Clinical data of the patients, such as age,
histological type, grade, and FIGO staging
are shown on Table 1.
RESULTS
The evaluation of the appropriateness of
radiotherapy field borders on sagittal MRI
sections demonstrated inappropriate AB in
20 (39.2%) of the patients, and geographic
miss in PB in 37.3% of cases (Figure 1).
No relation was observed between lat-
eral field AB inappropriateness and clini-
cal parameters such as patient’s age (p =
0.970), tumor staging (p > 0.999), type (p
= 0.162) and histological grade (p = 0.884).
Also, the PB inappropriateness was not
related with the clinical parameters, age (p
= 0.726), tumor staging (p > 0.999), type
(p = 0.496) and histological grade (p =
0.813).
As regards staging, a high rate of inap-
propriateness was observed in stages IIB
(AB, 37.9% and PB, 34.4%) and IIIB (AB,
Table 1 Clinical characteristics of patients in the study sample.
Sample characteristics
Age (median in years)
Histological type
Histological grade
Staging (FIGO)
n
–
45
6
10
3
25
13
3
29
15
4
Rate
–
88.2%
11.8%
19.6%
5.9%
49.0%
25.5%
5.9%
56.9%
29.4%
7.8%
54
Spinocellular carcinoma
Adenocarcinoma
X*
1
2
3
IB
IIB
IIIB
IVA
* Grade X: Histological grade not reported by the pathologist.
Figure 1. Distribution of individuals according to the appropriateness of anterior borders (A) and poste-
rior borders (B) of lateral fields.
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53.3% and PB, 46.6%), as the patients at
each specific stage were analyzed. Such
results demonstrate that no statistical sig-
nificance was observed in relation to the
evaluated parameters and, consequently,
errors may occur with any staging or his-
tological grade (Figure 2).
In the analysis of the appropriateness of
each histological grade, inappropriateness
was observed in 33.3% (AB) in histologi-
cal grade 1, 36% (AB) and 40% (PB) in
grade 2, and 46.2% (PB) in grade 3, also
demonstrating a greater planning error in
higher histological grades.
DISCUSSION
Radiotherapy is the main therapeutic
modality for locally advanced uterine cer-
vix tumors, and the radiotherapy planning
is essential for guaranteeing the treatment
appropriateness. Classically, bone refer-
ences were employed to define standard
radiotherapy field borders, without consid-
ering the tumor characteristics and the
patient’s individual data. In the present
study, the anterior and posterior borders of
the lateral field were analyzed by means of
MRI to evaluate the planned radiotherapy
fields appropriateness.
The present study results regarding pa-
tients’ characteristics show a median age at
the diagnosis of 54 years (22 to 77 years),
with predominance of spinocellular carci-
noma in 88.2% of cases and locally ad-
vanced staging in 94.1%. This histological
type of tumor is reported in the literature
as the most frequent one(9–11). There was a
predominance of the most undifferentiated
tumors with histological grades 2 (49%)
and 3 (25.5%). The median age observed
was similar to the ones found in other stud-
ies including patients with the same dis-
ease(9,11). Thus the present results corrobo-
rate the literature, except for those related
to predominant histological grades, since
studies evaluating the utilization of MRI in
radiotherapy planning have not taken this
parameter into consideration(7,12,13).
As the appropriateness of the lateral
field borders was evaluated, inappropriate-
ness was very frequently observed, both for
AB (39.2%) and for PB (37.3%). In a study
evaluating 25 sagittal MRI sections of pa-
tients with uterine cervix neoplasm, the
presence of lesion beyond the PB was ob-
served in six patients, demonstrating the
relevance of the image in the evaluation of
the lateral field borders(12).
Zunino et al. have applied the same
method in the MRI analysis, utilizing a
safety margin of 1.0 cm from the tumor and
from the uterine fundus, and have found in-
appropriateness of PB in 49% and of AB
in 8.8% of cases(7).
In another Brazilian study, inappropri-
ateness indices corresponding to 46% (AB)
and 40% (PB) have been observed(14). Such
results are similar to the ones observed in
the present study. The same authors present
an updating of these data with 80 patients,
reporting 36% geographic miss in the AB,
and 35% in the PB. In total, 56% of patients
presented some kind of inappropriateness.
In the present study, a significant relation
was observed between field border inap-
propriateness and anteroposterior tumor
diameter, displacement of the anterior rec-
tal wall, and tumor volume. The authors
suggest that such factors can be utilized as
risk predictors of geographic miss(13).
As regards staging according to the
FIGO classification, no significant influ-
ence from this factor on RT field borders
appropriateness or inappropriateness was
observed, maybe because of the absence of
imaging studies such as computed tomog-
raphy (CT) and MRI in this staging sys-
tem(15). However, the FIGO staging allows
a standardization of the pretreatment as-
sessment of patients in different regions of
the world, even in locations where the ac-
cess to more complex imaging methods is
difficult, for comparison of therapeutic
outcomes.
Another study has utilized the TNM
staging system to evaluate the appropriate-
ness of radiotherapy field borders, allow-
ing the assessment of lymph nodes involve-
ment. However, statistical analysis was not
performed because of the low number of
patients. Only a descriptive analysis was
performed, demonstrating a high number
of patients with staging T2B and absence
of lymph nodes involvement(16).
As regards the analysis of each specific
staging, the authors observed a high rate of
inappropriateness in stages IIB (AB, 37.9%
and PB, 34.4%) and IIIB (AB, 53.3% and
PB, 46.6%), with no statistical signifi-
cance. In the literature, Zunino et al. have
observed staging inappropriateness in
stages IB (AB, 0% and PB, 50%), IIA (AB,
0% and PB, 67%), IIB (AB, 5% and PB,
42%), IIIB (AB, 67% and PB, 33%) and
IVA (AB, 0% and PB, 100%)(7).
Thus, the results of the present study
demonstrate that the more advanced the
staging, the more extensive the geographic
miss. Maybe, a larger sample may provide
a statistical evidence of these data.
As regards the histological grade that
represents the tumor differentiation and
plays a relevant role in the pretreatment
evaluation of the disease, this parameter
demonstrated a rate of inappropriateness of
33.3% (AB) and 0% (PB) in grade 1; 36%
(AB) and 40% (PB) in grade 2; and 46.1%
(AB) and 46.1% (PB) in grade 3. These
results also demonstrate a greater planning
error in higher histological grades, al-
though this error is not significant. This
finding may be correlated with the fact that
higher histological grades are associated
with more advanced or more voluminous
Figure 2. Distribution of
individuals staging, ac-
cording to the appropriate-
ness of anterior borders
(A) and posterior borders
(B) of lateral fields (by
staging).
178
Freire GM et al.
Radiol Bras. 2010 Mai/Jun;43(3):175–178
tumors. In the reviewed literature on radio-
therapy field borders appropriateness
evaluation with MRI, the authors have not
evaluated this factor in relation to geo-
graphic miss(7,12,13).
Imaging methods such as CT and MRI
would be indicated in the pretreatment
evaluation for defining the tumor diameter
and volume, and assessment of pelvic
lymph nodes and parametrial invasion(17–
20)
. A meta-analyses of 57 studies demon-
strated the higher sensitivity of MRI as
compared with CT in the evaluation of
parametrial invasion(21). However, in a
multicentric, prospective study with 208
patients with uterine cervix neoplasm sub-
mitted to clinical evaluation according to
FIGO, helical CT and MRI compared with
surgical (pathological) findings, the au-
thors have observed that CT and MRI pre-
sented similar results in the evaluation of
parametrial invasion, and have concluded
that clinical examination was superior to
other studies. The authors have suggested
the imaging methods influence on the clini-
cal staging, and that such imaging studies
could improve the pretreatment staging of
patients(22).
A recent study demonstrates the rel-
evance of MRI as a prognostic factor in the
analysis of the tumor volume and uterine
invasion by the tumor, and of CT in the
evaluation of positive pelvic lymph
nodes(23).
The most recent National Comprehen-
sive Cancer Network (NCCN) guidelines
suggests the utilization of MRI and CT for
defining the therapy planning, but these
imaging methods do not influence the for-
mal staging, and the FIGO staging is con-
sidered as a standard for comparison be-
tween treatments(24).
Thus, although the high cost of MRI for
radiotherapy planning as a routine is one of
the main factors which makes the imple-
mentation of this method more difficult in
poor and developing countries, the results
of the present study, in conjunction with the
literature review, suggest that MRI plays an
extremely relevant role in the radiotherapy
planning for patients with uterine cervix
neoplasm, and this planning should be in-
dividualized, considering the tumor vol-
ume and anatomical variations(7,12,13,16).
Uterine cervix cancer plays a relevant role
as the third major cause of death in women
worldwide, with about 274,000 yearly
deaths, 78% of such deaths occurring in
developing countries(1). MRI can be benefi-
cial to optimize the treatment of these pa-
tients.
CONCLUSIONS
As a whole, the results of the present
study demonstrate that MRI is a relevant
tool for radiotherapy planning in patients
with uterine cervix cancer, allowing higher
accuracy in the definition of irradiation
field borders, thus reducing the incidence
of geographic miss. According to the
present results, the patient’s age, tumor
staging, histological type and grade are not
related to the radiotherapy field borders
inappropriateness.
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